-
Aug 01, 2024How Drugs Move And Change in Our Bodies: A Brief Introduction To Pharmacokine...A Brief Introduction to Pharmacokinetics -
Aug 01, 2024How To Develop New Drugs Faster And Safer: A Guide To Preclinical DMPK StudiesA Guide to Preclinical DMPK Studies
-
Aug 01, 2024The Vital Role Of Experimental Monkeys in Advancing Scientific ResearchThe Vital Role of Experimental Monkeys in Advancing Scientific Research
-
Aug 01, 2024Understanding Macaca Fascicularis (Cynomolgus Monkey): Key Characteristics An...Learn about the Long-Tailed Macaque, its characteristics, and its vital role in biomedical research, particularly at Prisys Biotechnology. Discover why this species is crucial f...
-
Aug 01, 2024Revolutionizing Metabolic Disease Treatment: Advancements And Challenges in P...Peptide drugs, comprised of short amino acid chains, are a class of pharmaceuticals that offer key advantages over traditional small molecule medicines and biologics, such as th...
-
Aug 01, 2024How To Evaluate The Safety Of Skin Products Before Clinical Trials?One of the challenges of non-clinical studies for skin products is that there are no specific guidelines or regulations for this type of product. However, there are some general...
-
Aug 01, 2024The Significant Role Of Experimental Monkeys in Innovative Drug Development: ...1. Monkeys: The Key to Innovative Drug Development Monkeys, specifically species such as Cynomolgus monkeys and rhesus monkeys, play a pivotal role in the field of innovative dr...
-
Aug 01, 2024Liver Toxicity As A Key Concern For SiRNA Drugs: A Comprehensive Analysis Tar...At Prisys Biotechnology, we acknowledge the growing interest in oligonucleotide-based drugs, particularly small interfering RNA (siRNA) therapeutics. siRNA represents the third ...
-
Aug 01, 2024Advancing SiRNA Therapeutics: Overcoming Challenges in Drug DevelopmentsiRNA (small interfering RNA) has gained significant attention in both academia and the pharmaceutical industry due to its potential in revolutionizing the treatment of various ...
-
Aug 01, 2024Application Prospects Of Gene Drugs Based On Lipid NanoparticlesIn 2018, the FDA approved the first gene drug based on lipid nanoparticles (LNPs) - SiRNA Patiiran (ONPATTRO; Alnylam) - for the treatment of polyneuropathy caused by hereditary...
